The Spot sign and Tranexamic acid on Preventing ICH growth- AUStralasia Trial

Lead PI: Prof Geoff Donnan & Prof Steve Davis

Status: Closed 

No. of Patients Currently Recruited: 100                              No. of Patients Required: 100

STOP-AUST aims to test if intracerebral haemorrhage (ICH) patients who have contrast extravasation on computed tomography angiography, the ‘spot sign’, have lower rates of haematoma growth when treated with tranexamic acid within 4.5 hours of stroke onset, compared to placebo. 

Trial URL:

24 June 2021